Overview
SHC market data
Price History
SHC price chart · 1M
- O
- 19.64
- H
- 19.71
- L
- 19.46
- C
- 19.47
- Vol
- 120,684.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $19.64
- Previous Close
- $19.54
- Day High
- $19.71
- Day Low
- $19.46
- 52 Week High
- $19.72
- 52 Week Low
- $14.27
- 7 Day Return
- +1.38%
- 30 Day Return
- +9.60%
- 90 Day Return
- +24.46%
- 1 Year Return
- +25.99%
- Daily Notional Volume
- $2.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 46.08 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.27 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.86 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.09 – $19.85 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5.4B · P/B 8.27 · P/S 4.56.
Company News
8-K filing — Sotera Health Co (SHC)SEC EDGAR · Aug 14, 2026, 11:17 AM
Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25Benzinga · Aug 7, 2026, 8:24 PM
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22Benzinga · Aug 7, 2026, 7:05 PM
Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25Benzinga · Aug 7, 2026, 5:10 PM
JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18Benzinga · Aug 7, 2026, 4:48 PM
Sotera Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.Benzinga · Aug 6, 2026, 5:39 PM
Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M EstimateBenzinga · Aug 6, 2026, 11:07 AM
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B EstBenzinga · Aug 6, 2026, 11:03 AM
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19Benzinga · Jun 24, 2026, 2:50 PM
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jun 5, 2026, 12:55 PM